World Healthcare Report
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from the world

World Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.

Press releases published on June 18, 2025

NY Top Docs Honors Dr. Azeem Khan as a 2025 Top Doctor

NY Top Docs Honors Dr. Azeem Khan as a 2025 Top Doctor

Dr. Azeem Khan has been reviewed and approved by NY Top Docs based on merit for 2025 FOREST HILLS, NY, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- Dr. Azeem Khan is a skilled Interventional Gastroenterologist with over 25 years of experience in …

Over the Counter (OTC) Analgesics Market Size Worth US$ 53 Billion with 5.2% CAGR by 2035: Fact.MR Report

Over the Counter (OTC) Analgesics Market Size Worth US$ 53 Billion with 5.2% CAGR by 2035: Fact.MR Report

OTC analgesics market to reach USD 52.97 billion by 2035, fueled by rising self-medication trends and growing demand for accessible pain relief. ROCKVILLE, MD, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- The global OTC analgesics market is …

Three-Dimensional Upgrade: Creative Biolabs Advances Antibody Engineering and Therapeutics

Three-Dimensional Upgrade: Creative Biolabs Advances Antibody Engineering and Therapeutics

Creative Biolabs recently rolled out a three-dimensional upgrade designed to make antibodies safer, more potent, and easier to develop. SHIRLEY, NY, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- Immunogenicity has long been a major bottleneck …

Respiratory Pathogen Testing Kits Market: Growth Outlook, Trends, and Future Forecast–2031

Respiratory Pathogen Testing Kits Market: Growth Outlook, Trends, and Future Forecast–2031

PORTLAND, OR, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- The global respiratory pathogen testing kits market was valued at $2.2 billion in 2021 and is projected to reach $3.7 billion by 2031, expanding at a CAGR of 5.5% from 2022 to 2031. This …

Ferulic Acid Market Size, Growth, Analysis, Opportunities and CAGR 6% from 2024 to 2035

Ferulic Acid Market Size, Growth, Analysis, Opportunities and CAGR 6% from 2024 to 2035

WILMINGTON, DE, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- According to a new report published by Allied Market Research, titled, “Ferulic Acid Market," The ferulic acid market was valued at $83.30 million in 2023, and is estimated to reach $167. …

Cholesterol Test Market Surging Toward $18.44 Billion by 2031

Cholesterol Test Market Surging Toward $18.44 Billion by 2031

PORTLAND, OR, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- The global cholesterol test market size was valued at $8.54 billion in 2021 and is projected to reach $18.44 billion by 2031, growing at a CAGR of 8% from 2022 to 2031. As heart-related …

Hospital Beds Market to Reach $7.15 Billion by 2031 Amid Rising Healthcare Needs

Hospital Beds Market to Reach $7.15 Billion by 2031 Amid Rising Healthcare Needs

PORTLAND, OR, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- The global hospital beds market was valued at $3.39 billion in 2021 and is projected to reach $7.15 billion by 2031, growing at a CAGR of 7.4% from 2022 to 2031. This substantial growth is …

Biomedical Warming and Thawing Devices Market to Reach $376.7 Million by 2031

Biomedical Warming and Thawing Devices Market to Reach $376.7 Million by 2031

PORTLAND, OR, UNITED STATES, June 18, 2025 /⁨EINPresswire.com⁩/ -- The global biomedical warming and thawing devices market was valued at $159.3 million in 2021 and is projected to reach $376.7 million by 2031, growing at a CAGR of 9.1% from 2022 to 2031. …

Lonseal® Launches LONBETON TOPSEAL: Concrete-Inspired Resilient Sheet Vinyl for Bold, Contemporary Spaces

Lonseal® Launches LONBETON TOPSEAL: Concrete-Inspired Resilient Sheet Vinyl for Bold, Contemporary Spaces

Lonseal® Flooring proudly announces the launch of LONBETON TOPSEAL, its latest innovation in resilient sheet vinyl flooring. CARSON, CA, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- Designed to capture the modern, industrial-chic aesthetic of …

JUARA Launches Miracle Tea Recovery Crème: Skin Support Through Life’s Natural Transitions

JUARA Launches Miracle Tea Recovery Crème: Skin Support Through Life’s Natural Transitions

JUARA, the skincare brand inspired by ancient Indonesian wellness traditions, recently launched their newest product: Miracle Tea Recovery Crème. NEW YORK, NY, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- JUARA, the skincare brand inspired by …

Davis Integrative Medicine Launches Enhanced Google Business Profile for Gainesville Residents

Davis Integrative Medicine Launches Enhanced Google Business Profile for Gainesville Residents

Davis Integrative Medicine celebrates a five-star review milestone on Google and unveils an optimized Google Business Profile. GAINESVILLE, FL, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- Davis Integrative Medicine, a top-tier provider of …

Japan CAR-T Cell Therapy Market Outlook: Innovations & Key Players - 2025-2033 | DataM Intelligence

Japan CAR-T Cell Therapy Market Outlook: Innovations & Key Players - 2025-2033 | DataM Intelligence

Japan CAR-T Cell Therapies Market grows at 16.3% CAGR, driven by rising cancer cases, R…

Bavarian Nordic sælger Priority Review Voucher for USD 160 mio.

Bavarian Nordic sælger Priority Review Voucher for USD 160 mio.

KØBENHAVN, Danmark, 18. juni 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået aftale om salg af sin Priority Review Voucher (PRV) for USD 160 mio. kontant. Bavarian Nordic blev tildelt voucheren i februar 2025 i forbindelse …

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million

COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement to sell its Priority Review Voucher (PRV) for a total cash consideration of USD 160 million. Bavarian Nordic was awarded the PRV in …

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Geneva, Switzerland, June 18, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will …

Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders

Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of novel, potentially transformative treatments Proceeds will fund four clinical studies: two related to the …

Biomea Fusion Announces Pricing of Public Offering of Securities

Biomea Fusion Announces Pricing of Public Offering of Securities

REDWOOD CITY, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced the pricing of its previously announced underwritten public offering consisting of (i) 19, …

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025

IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”) today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty …

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- This press release has been updated to reflect the correct timing of the funding round. Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service